Operating Expenses Summary of Mabion S.A.

Mabion S.A.'s latest annual operating expenses in 2023 was 59.52 Million PLN , up 16.62% from previous year.
Mabion S.A.'s latest quarterly operating expenses in 2024 Q1 was 13 Million PLN , up 14.16% from previous quarter.
Mabion S.A. reported a annual operating expenses of 39.49 Million PLN in annual operating expenses 2022, down -9.37% from previous year.
Mabion S.A. reported a annual operating expenses of 43.57 Million PLN in annual operating expenses 2021, down -20.25% from previous year.
Mabion S.A. reported a quarterly operating expenses of 13.6 Million PLN for 2024 Q3, down -12.72% from previous quarter.
Mabion S.A. reported a quarterly operating expenses of 13 Million PLN for 2024 Q1, up 14.16% from previous quarter.

Annual Operating Expenses Chart of Mabion S.A. (2023 - 2009)

Historical Annual Operating Expenses of Mabion S.A. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	59.52 Million PLN	16.62%
2022	39.49 Million PLN	-9.37%
2021	43.57 Million PLN	-20.25%
2020	54.64 Million PLN	-12.69%
2019	62.58 Million PLN	-1.25%
2018	63.38 Million PLN	3.22%
2017	61.4 Million PLN	11.81%
2016	54.92 Million PLN	906.12%
2015	-6.81 Million PLN	-25.74%
2014	-5.41 Million PLN	-35.02%
2013	-4.01 Million PLN	-23.54%
2012	-3.24 Million PLN	-132.96%
2011	9.85 Million PLN	323.46%
2010	2.32 Million PLN	506.48%
2009	383.79 Thousand PLN	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	15.45 Million PLN	18.8%
2024 Q3	13.6 Million PLN	-12.72%
2024 Q1	13 Million PLN	14.16%
2023 Q3	12.17 Million PLN	20.99%
2023 Q2	10.06 Million PLN	-19.54%
2023 FY	46.05 Million PLN	16.62%
2023 Q1	12.5 Million PLN	83.54%
2023 Q4	11.39 Million PLN	-6.41%
2022 Q3	15.41 Million PLN	95.78%
2022 Q1	8.97 Million PLN	12.67%
2022 FY	39.49 Million PLN	-9.37%
2022 Q4	6.81 Million PLN	-55.81%
2022 Q2	7.87 Million PLN	-12.26%
2021 FY	43.57 Million PLN	-20.25%
2021 Q4	7.96 Million PLN	-49.69%
2021 Q1	13.64 Million PLN	-13.19%
2021 Q3	15.83 Million PLN	151.9%
2021 Q2	6.28 Million PLN	-53.94%
2020 Q1	16.65 Million PLN	-1.39%
2020 Q4	15.72 Million PLN	56.85%
2020 FY	54.64 Million PLN	-12.69%
2020 Q3	10.02 Million PLN	-18.04%
2020 Q2	12.22 Million PLN	-26.59%
2019 Q4	16.89 Million PLN	19.11%
2019 FY	62.58 Million PLN	-1.25%
2019 Q1	14.18 Million PLN	-6.79%
2019 Q2	17.33 Million PLN	22.16%
2019 Q3	14.18 Million PLN	-18.17%
2018 Q1	13.86 Million PLN	-29.96%
2018 FY	63.38 Million PLN	3.22%
2018 Q3	11.5 Million PLN	-48.4%
2018 Q2	22.29 Million PLN	60.82%
2018 Q4	15.21 Million PLN	32.27%
2017 Q4	19.79 Million PLN	53.62%
2017 Q3	12.88 Million PLN	-11.01%
2017 Q2	14.48 Million PLN	1.69%
2017 Q1	14.24 Million PLN	-70.57%
2017 FY	61.4 Million PLN	11.81%
2016 Q2	13.35 Million PLN	565.27%
2016 Q1	2 Million PLN	11250.0%
2016 FY	54.92 Million PLN	906.12%
2016 Q4	48.39 Million PLN	2129.06%
2016 Q3	2.17 Million PLN	-83.74%
2015 Q1	506 Thousand PLN	126.32%
2015 Q2	1.38 Million PLN	173.27%
2015 FY	-6.81 Million PLN	-25.74%
2015 Q4	-18 Thousand PLN	-101.87%
2015 Q3	964 Thousand PLN	-30.28%
2014 FY	-5.41 Million PLN	-35.02%
2014 Q4	-1.92 Million PLN	-958.26%
2014 Q3	224 Thousand PLN	-13.18%
2014 Q2	258 Thousand PLN	79.17%
2014 Q1	144 Thousand PLN	110.89%
2013 Q1	233 Thousand PLN	117.36%
2013 Q3	116 Thousand PLN	-50.21%
2013 Q4	-1.32 Million PLN	-1239.66%
2013 Q2	233 Thousand PLN	0.0%
2013 FY	-4.01 Million PLN	-23.54%
2012 Q2	152 Thousand PLN	-59.68%
2012 Q4	-1.34 Million PLN	-829.55%
2012 FY	-3.24 Million PLN	-132.96%
2012 Q1	377 Thousand PLN	0.0%
2012 Q3	184 Thousand PLN	21.05%
2011 FY	9.85 Million PLN	323.46%
2010 FY	2.32 Million PLN	506.48%
2009 FY	383.79 Thousand PLN	0.0%

Peer Operating Expenses Comparison of Mabion S.A.

Name	Operating Expenses	Operating Expenses Difference
Bioceltix S.A.	15.38 Million PLN	-286.889%
BIOTON S.A.	57.55 Million PLN	-3.412%
Captor Therapeutics Spolka Akcyjna	79.91 Million PLN	25.52%
Molecure S.A.	31.73 Million PLN	-87.587%
NanoGroup S.A.	7.82 Million PLN	-660.504%
Pharmena S.A.	-32.76 Million PLN	281.663%
Poltreg S.A.	15.47 Million PLN	-284.633%
Pure Biologics Spólka Akcyjna	29.14 Million PLN	-104.234%
Ryvu Therapeutics S.A.	4.73 Million PLN	-1156.268%
Synthaverse S.A.	26.35 Million PLN	-125.856%
Urteste S.A.	5.96 Million PLN	-897.353%

Global Stocks Search

Mabion S.A. (MAB.WA)

Operating Expenses Summary of Mabion S.A.

Annual Operating Expenses Chart of Mabion S.A. (2023 - 2009)

Historical Annual Operating Expenses of Mabion S.A. (2023 - 2009)

Peer Operating Expenses Comparison of Mabion S.A.